HYDERABAD, India--(BUSINESS WIRE)--Lipicard’s KeraKlear 0.05% is another high therapeutic index drug developed through its novel platform technology. Lipicard has developed a large number of high therapeutic index drugs in many therapeutic areas including cardiology, NSAID, immunosuppressant etc., using a novel platform technology.
